Psychiatry · 2 h ago
Review examines tryptophan metabolism and depression heterogeneity
A review in *Molecular Psychiatry* synthesizes evidence on how gut microbiota-related tryptophan metabolism may contribute to depression’s biological and clinical heterogeneity. It discusses the kynurenine, serotonin and microbial indole pathways, along with emerging therapeutic approaches; it does not report a new clinical trial.
- Reviews three tryptophan-metabolism pathways linked to the gut–brain axis.
- Discusses metabolic profiles across several depressive phenotypes.
- Surveys proposed therapies but reports no trial-level outcomes.
- Authors call for longitudinal and mechanistic studies.
Depression varies in its clinical presentation, treatment response and course. This review examines evidence linking tryptophan metabolism, gut microbiota and gut–brain communication to depression, focusing on three pathways: kynurenine, serotonin and microbial indole metabolism. The authors discuss how these pathways may influence neuroimmune signaling, neurotransmitter function and communication between the gut and brain.
The review describes reported differences in microbiota-dependent tryptophan metabolism across clinical, demographic, immunometabolic, trauma-related and genetically defined depressive phenotypes. It also surveys proposed therapeutic approaches, including pharmacological, nutritional, microbial and traditional Chinese medicine-based interventions. The abstract provides no pooled effect estimates or trial-level outcome data.
The authors frame tryptophan metabolism as a potential biological framework for understanding depression heterogeneity, while emphasizing that further work is needed to establish causal relationships. They call for multi-omics research, longitudinal designs and mechanistic validation. The review highlights therapeutic opportunities, but the information provided does not establish that any approach is effective or supports changes to clinical practice.
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Molecular Psychiatry: Tryptophan metabolism within the gut–brain axis in depression: mechanisms, association with heterogeneity, and therapeutic opportunities ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.